Global research trends in CAR-T cell therapy for glioblastoma: a bibliometric and visualized analysis
This study maps the evolving scientific landscape of CAR-T cell therapy in GBM, highlighting key contributors, institutional collaboration, and emerging research frontiers. The transition from basic antigen targeting to multifunctional, immune-enhancing strategies reflects a maturing field with increasing translational focus. Our findings offer valuable insights that can inform strategic funding allocation by identifying high-impact institutions and authors, optimize clinical trial design by highlighting emerging combinatorial and delivery strategies, and guide novel target discovery through analysis of co-cited references and keyword bursts. By revealing global collaboration networks and thematic shifts, this study also supports the development of interdisciplinary research frameworks in CAR-T therapy for GBM.
Authors
- Yu Duan (ORCID: https://orcid.org/0000-0003-1113-7953)
- Xuhao Fang (ORCID: https://orcid.org/0000-0002-3733-3568)
- Dongwei Dai
- Guohui Huang (ORCID: https://orcid.org/0000-0002-1904-5407)
- Yao Deng (ORCID: https://orcid.org/0000-0002-9411-9250)
- Lichun Lu (ORCID: https://orcid.org/0000-0003-2907-3230)
- Jian Li (ORCID: https://orcid.org/0000-0001-7953-8230)
- Feng Jiang (ORCID: https://orcid.org/0000-0003-4938-7798)
- Feng Tang (ORCID: https://orcid.org/0000-0001-6241-8400)
Institutions
- Huadong Hospital (CN)
- Suzhou Municipal Hospital (CN)
- Obstetrics and Gynecology Hospital of Fudan University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-09-29
- DOI
- https://doi.org/10.1007/s12672-025-03285-6
- Citations
- 2
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 2.09